This is a renewal application from Columbia University that requests funding for postdoctoral training program in digestive and liver diseases. The program is designed to train M.D. investigators to become independent basic, clinical and translational researchers. The program has been in existence for four years and to date has been highly successful in its mission. The training program has been focused initially on training adult gastroenterologists, but now seeks to expand to include a rapidly growing pediatric GI division. Both divisions now put a primary emphasis on research training in both the selection and training of their fellows. The program faculty, while drawing primarily from adult and pediatric GI divisions, now includes faculty from many departments. Trainees are assigned to a mentor in basic or clinical epidemiology research, and are given a specific research project, but also complete a rigorous program of didactic instruction that includes cross training and multidisciplinary educaiton. All trainees will be exposed to basic laboratory investigation and receive training in biostatistics and clinical trial design. This NIH training program builds upon very strong and academic fellowships in pediatric and adult GI, which are now developing many young academic faculty in these disciplines. Dr. Timothy C. Wang is the PI and Director of this training program, but ably assisted by Associate Directors Drs. Joel Lavine and Howard Worman. All three program leaders have actively mentored young basic and clinical scientists for many years, and have superb track records in training. The program is supported by both Internal and External Advisory Committees, and is tightly integrated with the Columbia University CTSA and MS/POR training programs.Strong emphasis is given to the recruitment of underrepresented ethnic groups and to training in ethical and responsible conduct.

Public Health Relevance

This training program addresses our need for more researchers in digestive and liver disease. Approximately 60 to 70 million Americans are affected each year by digestive diseases at a cost of >$90 billion in direct costs. Many more researchers are needed to advance our knowledge of digestive disease pathogenesis, prevention and treatment. Columbia University, a top ten research center, is ideally suited as a training site.

National Institute of Health (NIH)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Digestive Diseases and Nutrition C Subcommittee (DDK)
Program Officer
Densmore, Christine L
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Columbia University (N.Y.)
Internal Medicine/Medicine
Schools of Medicine
New York
United States
Zip Code
Hassid, Benjamin G; Lucas, Aimee L; Salomao, Marcela et al. (2014) Absence of pancreatic intraepithelial neoplasia predicts poor survival after resection of pancreatic cancer. Pancreas 43:1073-7
Hillyer, Grace Clarke; Schmitt, Karen M; Freedberg, Daniel E et al. (2014) Fecal-based colorectal cancer screening among the uninsured in northern Manhattan. Am J Prev Med 47:182-7
Freedberg, Daniel E; Abrams, Julian A; Wang, Timothy C (2014) Prevention of gastric cancer with antibiotics: can it be done without eradicating Helicobacter pylori? J Natl Cancer Inst 106:
Freedberg, Daniel E; Lebwohl, Benjamin; Abrams, Julian A (2014) The impact of proton pump inhibitors on the human gastrointestinal microbiome. Clin Lab Med 34:771-85
Sharaiha, Reem Z; Freedberg, Daniel E; Abrams, Julian A et al. (2014) Cost-effectiveness of chemoprevention with proton pump inhibitors in Barrett's esophagus. Dig Dis Sci 59:1222-30
Lucas, Aimee L; Shakya, Reena; Lipsyc, Marla D et al. (2013) High prevalence of BRCA1 and BRCA2 germline mutations with loss of heterozygosity in a series of resected pancreatic adenocarcinoma and other neoplastic lesions. Clin Cancer Res 19:3396-403
Lucas, Aimee L; Chang, Michelle M; Lipsyc, Marla D et al. (2013) The prevention and genetics of pancreatic cancer: a programmatic approach. Methods Mol Biol 980:205-14
Freedberg, Daniel E; Salmasian, Hojjat; Friedman, Carol et al. (2013) Proton pump inhibitors and risk for recurrent Clostridium difficile infection among inpatients. Am J Gastroenterol 108:1794-801
Diehl, Gretchen E; Longman, Randy S; Zhang, Jing-Xin et al. (2013) Microbiota restricts trafficking of bacteria to mesenteric lymph nodes by CX(3)CR1(hi) cells. Nature 494:116-20
Amin, Sunil; Lucas, Aimee L; Frucht, Harold (2013) Evidence for treatment and survival disparities by age in pancreatic adenocarcinoma: a population-based analysis. Pancreas 42:249-53